article thumbnail

Biopharma M&A in 2024 β€” Five Considerations for Deal Execution

Vantage Partners

Analysis from EY found that life sciences M&A spend was up 34% last year relative to 2022, despite a reduction in deal volume. It’s no great secret that M&A activity in bipoharma has been on the rise over the past 12 months.

article thumbnail

Alliance Launch: The First Hundred Days

Vantage Partners

We’ve identified a number of deliverables that typically must be created in the first 100 days of a life sciences alliance launch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alliance Launch: The First Hundred Days

Vantage Partners

Over the course of our 25 years in the business, we've realized that when a life sciences company launches a complex alliance, the plan tends to gravitate towards two simultaneous paths: one focused on getting the work done and achieving specific milestones, and the other focused on setting things up (e.g.,

article thumbnail

Reflections on 2020 ASAP BioPharma Conference: The right mindset is more important than ever

Vantage Partners

In case you missed them during the conference, Stu Kliman and Ben Siddall led a session on β€œEnhancing Partnerships between Life Sciences and Digital Organizations” and Mai-Tal Kennedy moderated a panel with Petra Sansom, Jay Vora, and Vin Sharma about β€œMaking a Positive Impact on New Drug Modality Alliances.”.

article thumbnail

Virtual Alliance Launch Best Practices

Vantage Partners

This past year, alliance launches across the life sciences industry shifted from in-person to completely virtual.